Pediatric Oncology

Top Story

TARE-Y90 safe, effective for unresectable pediatric liver tumors

TARE-Y90 safe, effective for unresectable pediatric liver tumors
November 8, 2018

HemOnc Today launches Cell Therapy Next

November 5, 2018
THOROFARE, NJ – With the approval of two chimeric antigen receptor T-cell therapies in the past year, the need arose for quality information and education about…

Rutgers Cancer Institute section chief receives distinguished service award

November 4, 2018
Richard Drachtman, MD, received the Distinguished Service Award from Melvyn H. Motolinsky Research Foundation, established to support research into leukemia and other…

Collaborative aims to accelerate immunotherapy development for pediatric cancers

October 12, 2018
Experts from several health systems have launched CureWorks, a collaborative effort to accelerate the development of immunotherapies for children with cancer…
More Headlines »

Decisions, Decisions: Differentiating Checkpoint Inhibitors for Bladder Cancer

This activity is supported by an educational grant from AstraZeneca Pharmaceuticals LP.

Lung cancer is a leading cause of cancer death worldwide. The American Cancer Society estimates that there will be…
More »

Baseball Hall of Famer: Physician’s confidence affects patients

September 26, 2017
More »

Ace the Case: A 52-Year-Old Man with an Asymptomatic Neck Mass

There is no commercial support for this activity.

This educational activity will discuss the approach to diagnosis and management of a 52-year-old man who presents with…
More »